Jay Cross joined Sonnet BioTherapeutics in May 2019 and serves as the Chief Financial Officer. Prior to Sonnet, Mr. Cross was a Managing Director with Chardan Capital’s healthcare investment banking team, where he focused on biopharmaceuticals. From 2002 to 2014, Mr. Cross worked as an analyst and portfolio manager specializing in therapeutics for several global institutional investment firms. He launched his career in finance in 1999 as an associate analyst covering biotechnology on the healthcare equity research team at Hambrecht & Quist.
Mr. Cross earned a Master of Public Health from the Yale University School of Medicine and a Bachelor of Science in psychology from Washington & Lee University.
Current role
Director, Representative Executive Officer, EVP, Global, Chief Governance Officer & CFO at Dentsu International
CFO at Athletes First
President And CFO at Paccar
VP Finance / Cfo, Hershey International at The Hershey Company
CFO & Co-Founder at Turbi
Access the worlds's biggest network of public org charts
Learn more